期刊文献+

系统性红斑狼疮患者血清中IL-18、IL-10和IFN-γ的变化 被引量:1

Changes of serum IL-l8,IL-10 and IFN-γ in patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的:探讨IL-18、IL-10和IFN-γ水平变化与系统性红斑狼疮(systemic lupus erythematosus,SLE)发病的关系。方法:采用ELISA法检测SLE患者52例、对照组48例血清IL-18、IL-10和IFN-γ的水平。结果:SLE组IL-18(265.7±78.3)pg/mL、IL-10(78.2±2.2)pg/mL、IFN-γ(22.4±9.2)pg/mL较正常对照组IL-18(184.1±63.6)pg/mL、IL-10(18.3±6.4)pg/mL、IFN-γ(12.5±5.1)pg/mL有高度显著性差异(P<0.01),且活动期SLE患者IL-18(382.7±156.4)pg/mL、IL-10(90.8±12.9)pg/mL与非活动组IL-18(91.3±48.6)pg/mL、IL-10(45.1±15.4)pg/mL之间比较有高度显著差异(P<0.01),活动期IFN-γ(26.8±9.8)pg/mL和非活动期患者IFN-γ(18.9±9.1)pg/mL之间比较无显著性差异(P>0.05)。结论:SLE患者IL-18、IL-10水平增高,且与疾病活动性有关,可作为判断疾病疗效的监测指标。SLE患者血清IFN-γ水平也显著提高,表明在SLE患者中,参与炎症反应可能既有Th1型细胞因子,也有Th2型细胞因子。 Objective: To investigate the correlation between the changes of serum IL-18, IL-10 and IFN-γ and systemic lupus erythematosus (SLE). Methods: The levels of IL-18,IL-10 and IFN-γ from 52 patients with SLE and 48 normal control were determined with sandwich ELISA. Results.The levels of IL- 18(265. 7±156.4)pg/mL,IL-10(78.2±2.2) pg/mL and IFN-γ (22.4±9.2)in SLE were significant higher than those of in control group (P〈0.01). And there were significant differences between active SLE patients IL-18(382. 7±156.4) pg/mL and IL-10 (90.8±12. 9) pg/mL) and inactive patients IL-18(91.3± 48.6) pg/mL and IL-10(45.1±15.4) pg/mL)(P〈0. 01). The level of IFN-γ in both active and inactive SLE was no significant difference (P〉0.05). Conclusion: The levels of IL-18 and IL-10 are increased in active patients with SLE and may play a significant role in the curative effect of SLE. There was significant difference between SLE group and control group in level of IFN-γ. Abnormally high expression of Th1 and Th2 cytokines might contribute to the inflammatory damages of SLE.
出处 《海南医学院学报》 CAS 2007年第2期120-122,124,共4页 Journal of Hainan Medical University
关键词 红斑狼疮 系统性 白细胞介素10 白细胞介素18 干扰素 Lupus erythematosus, systemic Interlukin-18 Interlukin-10 Interferon
  • 相关文献

参考文献10

  • 1钱学贤,戴玉华.孔华宇.现代心血管病学[M].北京:人民军医出版社,1995.618-620. 被引量:1
  • 2Urowitz MB,Gladman DD,Tozman ECS,et al.The lupus activity criteria count(LAcC)[J].Pheumatol,1984,11:783. 被引量:1
  • 3Yu C.Expression of Th1/Th2 cytokine mrRNA in peitoneal exudative polymorphonuclear neutrophils and their effects on mononuclear cell Th1/Th2 cytokine production in MRLLpr/Lprmice[J].Immunology,1998,95(3):480-487. 被引量:1
  • 4周燕斌,李幼姬,吴玉红.狼疮肾炎患者血清及外周血单个核细胞中IL-10和γ干扰素的表达及意义[J].中国现代医学杂志,2006,16(4):529-532. 被引量:12
  • 5Wong CK,Ho CY,Li EK,et al.Elevation of proinflammatory cytokine(IL-18,IL-17,IL-12)and Th2 cytokine(IL-4)concentrations in patients with systemic lupus erythematosus[J].Lupus,2000,9(8):589-593. 被引量:1
  • 6Kawashima M,Yamamura M,Taniai M,et al.Levels of interleukin-1 8 and its binding inhibitors in the blood circulation of patients with adult-onset Stillrs disense[J].Arthritis Rheum,2001,44(3):550-560. 被引量:1
  • 7Masutani K,Akahoshi M,Tsuruya K,et al.Predominance of Th1 immne response in diffuse proliferative lupus nephritis[J].Arthritis Rheum,2001,44(9):2097-2106. 被引量:1
  • 8Liorente L,Richaud-patin Y,Couderc J,et al.Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus[J].Arthritis Rheum,1997,40(8):1429-1435. 被引量:1
  • 9Eskdale J,Wordsworth P,Bowman S,et al.Association between polymorphisms at the humanIL-10 locus and systemic lupus erythematosus[J].Tissue Antigens,1997,49(6):635-639. 被引量:1
  • 10Tokano Y,Morimoto S,Kaneko H,et al.Levels of IL-12 in the sera of patients with systemic lupus erythematosus(SLE)-relation to Th1-and Th2-derived cytokines[J].Clin Exp Immunol,1999,116:169-173. 被引量:1

二级参考文献12

  • 1孙雪峰,苏金环,叶任高.中西医结合治疗狼疮性肾炎的荟萃分析(英文)[J].中国现代医学杂志,2004,14(17):23-28. 被引量:5
  • 2叶任高.系统性红斑狼疮内科学[M].第5版.北京:人民卫生出版社,2000:909-915. 被引量:1
  • 3BOMBARDIER C,GLADMAN DD,UROWITZ MB,et al.Derivation of the SLEDAI:A disease activity index for lupus patients.The committee on prognosis studies in SLE[J].Arthritis Rheum,1992,35(6):630-640. 被引量:1
  • 4MOSMANN TR,SAD S.The expanding universe of T-cell subsets:Th1,Th2 and more[J].Immunol Today,1996,17(3):138-146. 被引量:1
  • 5LIORENTE L,ZOU W,LEVY Y,et al.Role of interleukin 10in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus[J].J Exp Med,1995,181(3):839-844. 被引量:1
  • 6TAGA K,MOSTOWSKI H,TOSATO G.Human interleukin 10can directly inhibit T cell growth[J].Blood,1993,81 (11):2964-2971. 被引量:1
  • 7ISHIDA H,MUCHAMUEL T,SAKAGUCHI S,et al.Continuous administration of anti-interleukin10 antibodies delays the onset of autoimmunity in NZB/W F1 mice[J].J Exp Med,1994,179(1):305-310. 被引量:1
  • 8LIORENTE L,RICHAUD-PATIN Y,COUDERC J,et al.Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus[J].Arthritis Rheum,1997,40(8):1429-1435. 被引量:1
  • 9ESKDALE J,WORDSWORTH P,BOWMAN S,et al.Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus[J].Tissue Antigens,1997,49(6):635-639. 被引量:1
  • 10BALOMENOS D,RUMOLD B,THEOFILOPOULOS AN.Interferon-γ in required for lupus-like disease and lymphoaccumulation in MRL/lpr mice[J].J Clin Invest,1998,101(2):364-371. 被引量:1

共引文献11

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部